Rezultati pretraživanja
  1. 6. pro 2019.

    A little Angelman Syndrome 101! This science teacher is nerding out on all the genetic information being shared! 💜🧬

  2. 6. pro 2019.

    Joe Anderson of @UcdavisT presents his data showing near complete rescue of deficits in adult mice at

    Prikaži ovu nit
  3. 6. pro 2019.

    Roche/Genentech announces a clinical trial will start in 2020 of their antisense oligonucleotide (ASO/LNA)! They tested 2500 ASOs then tested the best one in monkeys, showing an increase in both UBE3A mRNA and protien. This is great news for .

  4. 6. pro 2019.

    Ionis announces they will start a clinical trial for their ASO targeting in late 2020! Looks like 2020 will be remembered as the turning point in the fight against Angelman!

  5. 6. pro 2019.

    trumacro is at the annual summit for FAST and our team is thrilled to talk with families of children with Angelman Syndrome. We are handing out samples of trumacro Ketogenic BHB+MCT.

  6. 6. pro 2019.

    Glad to be at with the team, meeting families & learning about scientific progress in understanding & treating .

  7. 6. pro 2019.
    Odgovor korisnicima i sljedećem broju korisnika:

    Thank you! Hope everyone has a wonderful weekend. I’m looking forward to checking out Chicago’s holiday decorations tonight & tomorrow afternoon while I am here for .

  8. 6. pro 2019.

    Ionis Pharmaceuticals has announced their ASO will be headed to clinical trial in the 2nd half of 2020! We have been watching the dramatic & beneficial affect of these therapies for other disorders. Now it is our turn.

    Prikaži ovu nit
  9. 9. pro 2019.

    At , I announced progress in the ongoing clinical development of OV101, our investigational therapy for and syndrome. ()

  10. 22. sij

    If you missed the update on Ovid’s OV101 STARS & NEPTUNE, presented last month at the , by our President & Chief Medical Officer , you can watch it online at .

  11. 9. pro 2019.

    That wraps up our ! If you’d like to ask a question, reply below and we’ll try to follow-up. ()

  12. 6. pro 2019.

    *SCIENCE SUMMIT ANNOUNCEMENT* GeneTx, in partnership with Ultragenyx, Inc,. has announced that their gene altering ASO therapy will be headed to clinical trial in the FIRST half of 2020!

  13. 6. pro 2019.

    Neuren Pharmaceuticals, Inc. announces their drug NNZ-2591 will begin phase 1 trials in Australia with Phase 2 trials in the US in the second half of 2020!

  14. 6. pro 2019.
  15. 6. pro 2019.

    Great things happening in research for potential therapies for Angelman’s Syndrome. Thanks Dr. Allyson Berent.

  16. 6. pro 2019.

    Here’s Ryan Dant in 2018. The story of hope and determination for the treatment of a rare genetic disease by a father, a foundation, and a researcher. Thanks for this Emil Kakkis.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.